Characterizing unmet medical need and the potential role of new biologic treatment options in patients with ulcerative colitis and Crohn’s disease: a systematic review and clinicia...

by Gordon, Jason P., McEwan, Phil C., Maguire, Andy, Sugrue, Daniel M., Puelles, Jorge
Published 2015

Assessing the Long-Term Impact of Treating Hepatitis C Virus (HCV)-Infected People Who Inject Drugs in the UK and the Relationship between Treatment Uptake and Efficacy on Future I...

by Bennett, Hayley, McEwan, Phil, Sugrue, Daniel, Kalsekar, Anupama, Yuan, Yong
Published 2015

Human cytomegalovirus suppresses Fas expression and function

by Seirafian, Sepehr, Prod’homme, Virginie, Sugrue, Daniel, Davies, James, Fielding, Ceri, Tomasec, Peter, Wilkinson, Gavin W. G.
Published 2014

Human cytomegalovirus UL141 promotes efficient downregulation of the natural killer cell activating ligand CD112

by Prod'homme, Virginie, Sugrue, Daniel M., Stanton, Richard J., Nomoto, Akio, Davies, James, Rickards, Carole R., Cochrane, Daniel, Moore, Melanie, Wilkinson, Gavin W. G., Tomasec, Peter
Published 2010

Plasma Membrane Profiling Defines an Expanded Class of Cell Surface Proteins Selectively Targeted for Degradation by HCMV US2 in Cooperation with UL141

by Hsu, Jye-Lin, van den Boomen, Dick J. H., Tomasec, Peter, Weekes, Michael P., Antrobus, Robin, Stanton, Richard J., Ruckova, Eva, Sugrue, Daniel, Wilkie, Gavin S., Davison, Andrew J., Wilkinson, Gavin W. G., Lehner, Paul J.
Published 2015

Two Novel Human Cytomegalovirus NK Cell Evasion Functions Target MICA for Lysosomal Degradation

by Fielding, Ceri A., Aicheler, Rebecca, Stanton, Richard J., Wang, Eddie C. Y., Han, Song, Seirafian, Sepehr, Davies, James, McSharry, Brian P., Weekes, Michael P., Antrobus, P. Robin, Prod'homme, Virginie, Blanchet, Fabien P., Sugrue, Daniel, Cuff, Simone, Roberts, Dawn, Davison, Andrew J., Lehner, Paul J., Wilkinson, Gavin W. G., Tomasec, Peter
Published 2014